The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
We expect the global guidewires market to exhibit a CAGR of 4.17% during 2022-2027.
Sudden outbreak of the COVID-19 pandemic had negatively impacted the demand for guidewires in conducting various medical procedures to mitigate the risk of coronavirus infection upon hospital visits or interaction with healthcare professionals.
The growing occurrence of chronic medical ailments, such as cardiovascular, urological and neurovascular disorders, especially among the geriatric population is currently driving the market for guidewires.
Based on the product, the market has been bifurcated into surgical guidewires and diagnostic guidewires. Currently, surgical guidewires hold the largest market share.
Based on the material, the market has been classified into nitinol, stainless steel, and others. Nitinol currently exhibits a clear dominance in the market.
Based on the application, the market has been divided into coronary, neurovascular, urology, and others. Currently, coronary holds the largest market share.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global guidewires market include Abbott Laboratories, AngioDynamics Inc., ASAHI INTECC Co., Ltd., B. Braun (B. Braun Holding GmbH & Co. KG), Boston Scientific, C. R. Bard Inc. (Becton, Dickinson and Company), Cardinal Health, Cook Medical Incorporated (Cook Group), Johnson & Johnson, Medtronic Plc, Merit Medical Systems Inc., Olympus Corporation, Stryker Corporation, Teleflex Medical Inc. and Terumo Corporation.
Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at